New scan could spot hidden prostate cancer early

NCT ID NCT06970847

Ongoing Diagnosis Sponsor: Clarity Pharmaceuticals Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 study tests a new type of PET scan (64Cu-SAR-bisPSMA) to see if it can better detect prostate cancer that has come back after initial treatment. The study involves 220 adults with a rising PSA level after surgery or radiation. The goal is to improve detection so doctors can plan the right treatment sooner.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hormone-resistant prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRYOTHERAPY PROSTATE CANCER PROSTATE CANCER - RECURRENT PROSTATE CANCER PATIENTS TREATED BY RADIOTHERAPY PROSTATE CANCER PATIENTS WHO HAVE BRACHYTHERAPY SEED IMPLANT PROSTATE CANCER PATIENTS WITH DETECTABLE PSA FOLLOWING PROSTATECTOMY

Contacts and locations

Locations

Alarcon Urology Center

Montebello, California, 90640, United States
Albany Medical College

Albany, New York, 12208, United States
Biogenix Molecular

Miami, Florida, 33165, United States
Carolina Urologic Research Center

Myrtle Beach, South Carolina, 29572, United States
Comprehensive Urology Medical Group

Los Angeles, California, 90048, United States
Endeavor Health- Glenbrook Hospital

Glenview, Illinois, 60201, United States
Indiana University Health-IU Simon Cancer Center

Indianapolis, Indiana, 46202, United States
Intermountain Medical Center

Salt Lake City, Utah, 84111, United States
M. Health Fairview University of Minnesota Medical Center

Minneapolis, Minnesota, 55455, United States
Royal Brisbane and Women's Hospital

Herston, Queensland, 4029, Australia
St. Louis University

St Louis, Missouri, 63103, United States
St. Vincent's Hospital, Sydney

Darlinghurst, New South Wales, 2010, Australia
Summit Urology

Murray, Utah, 84107, United States
Sydney Adventist Hospital

Wahroonga, New South Wales, 2076, Australia
The Urology Place

San Antonio, Texas, 78240, United States
UC Irvine

Irvine, California, 92697, United States
University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, 15260, United States
Urology Associates, P.C.

Nashville, Tennessee, 37209, United States
Urology Clinics of North Texas

Dallas, Texas, 75231, United States
Westmead Private Hosptial

Westmead, New South Wales, 2145, Australia
XCancer

Omaha, Nebraska, 68130, United States
XCancer Research Network / LCMC Health EJGH

Metairie, Louisiana, 700006, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.